If you don't currently have sufficient funds to invest across a large number of different shares, then exchange traded funds (ETFs) could be the answer.
ETFs allow you to invest in a particular theme, index, or industry through just a single investment.
There are countless ETFs out there for investors to choose from, but three of my favourites are listed below. Here's why I like them:
BetaShares Asia Technology Tigers ETF (ASX: ASIA)
The BetaShares Asia Technology Tigers ETF could be a top option for ASX investors. This fund tracks the performance of an index of the 50 largest technology and online retail companies that have their main area of business in Asia (excluding Japan). These companies are among the fastest-growing in the region and look exceptionally well-positioned to be market-beaters over the next decade. Among its biggest holdings you'll find the likes of Alibaba, Baidu, JD.com, and Tencent.
BetaShares NASDAQ 100 ETF (ASX: NDQ)
Another exchange traded fund which I think has the potential to outperform the ASX 200 is the BetaShares NASDAQ 100 ETF. As you might have guessed from its name, this exchange traded fund gives investors exposure to the 100 largest businesses on Wall Street's technology-focused NASDAQ index. As a result, through a single investment investors will be getting a slice of tech behemoths such as Amazon, Apple, Alphabet, Facebook, Microsoft, and Netflix. Other notable holdings include Starbucks, Tesla, and Zoom.
iShares Global Healthcare ETF (ASX: IXJ)
A final exchange traded fund to consider buying is the iShares Global Healthcare ETF. I think this is a great option for investors that are looking for exposure to the healthcare sector. This is because this exchange traded fund gives investors access to many of the biggest and brightest healthcare companies in the world. This includes CSL Ltd (ASX: CSL), Johnson & Johnson, Novartis, Ramsay Health Care Limited (ASX: RHC), and Sanofi. Given the positive outlook for the healthcare sector over the next couple of decades due to ageing populations and increased chronic disease, I believe it could provide strong returns for investors,
